Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,127 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC(CHER@NOS) | completed | Phase 2 | 77 | University Hospital, AntwerpOTHER | 1 | Jul 12, 2013 |
| clinicaltrials |
| NCT00771563 | Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)(SYRINGES) | completed | Phase 3 | 104 | University Hospital, AntwerpOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00992186 | A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer | completed | Phase 2 | 46 | Centocor Research & Development, Inc.INDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.(SPRAY) | completed | Phase 2 | 360 | GW Pharmaceuticals LtdINDUSTRY | 16 | Jun 20, 2013 | clinicaltrials |
| NCT00537381 | An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer | completed | Phase 2 | 131 | Centocor, Inc.INDUSTRY | 10 | Jun 20, 2013 | clinicaltrials |
| NCT01459757 | Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib | completed | — | 322 | PfizerINDUSTRY | 16 | Jun 19, 2013 | clinicaltrials |
| NCT01537536 | Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer(EndoTAG-1) | completed | Phase 2 | 18 | Jules Bordet InstituteOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT01686425 | Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage(PETRUS) | unknown | N/A | 60 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jun 13, 2013 | clinicaltrials |
| NCT00002700 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | completed | Phase 3 | 392 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jun 12, 2013 | clinicaltrials |
| NCT00002990 | Surgery and BCG in Treating Patients With Bladder Cancer | completed | Phase 3 | 1,288 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | completed | Phase 2 / Phase 3 | 238 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | completed | Phase 3 | 608 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 16 | Jun 12, 2013 | clinicaltrials |
| NCT01032291 | A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer | terminated | Phase 2 | 51 | Celgene CorporationINDUSTRY | 6 | May 21, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT01005693 | Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment | unknown | N/A | 300 | Ziekenhuis Netwerk Antwerpen (ZNA)OTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00055887 | Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Spectrum Pharmaceuticals, IncINDUSTRY | 4 | May 10, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT01837173 | Multicentric Retrospective Review of Extracapsular Lymph Node Involvement After Esophagectomy(ECLNI-MC) | unknown | — | 2,000 | University Hospital, GasthuisbergOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01837186 | Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC) | completed | — | 600 | University Hospital, GasthuisbergOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT00698243 | Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 128 | Astellas Pharma IncINDUSTRY | 3 | Apr 15, 2013 | clinicaltrials |
| NCT01824966 | Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma(SRCC) | completed | — | 82 | University Hospital, GasthuisbergOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT00560573 | Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 | 46 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT01812486 | Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer | completed | Phase 3 | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT01025206 | A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma | completed | Phase 1 | 35 | BioInvent International ABINDUSTRY | 4 | Mar 15, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 31 | Mar 4, 2013 | clinicaltrials |
| NCT00107016 | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women | completed | Phase 2 | 267 | Novartis PharmaceuticalsINDUSTRY | 10 | Mar 4, 2013 | clinicaltrials |
| NCT00988741 | Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy | completed | Phase 2 | 107 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 5 | Feb 28, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT01303328 | Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)(Colvir-PhaseII) | completed | Phase 2 | 200 | Mithra PharmaceuticalsINDUSTRY | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00464633 | Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 165 | SanofiINDUSTRY | 9 | Feb 12, 2013 | clinicaltrials |
| NCT00004934 | Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | completed | Phase 3 | — | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 10 | Feb 4, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT01138748 | Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers(PEARL-2) | terminated | Phase 2 | 5 | University Hospital, GhentOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00050141 | Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer | completed | Phase 2 | 121 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 6 | Feb 1, 2013 | clinicaltrials |
| NCT01780766 | Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging | unknown | — | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT01780779 | Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults(FUBEO) | unknown | — | 25 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00622349 | Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer | completed | Phase 3 | 707 | European Lung Cancer Working PartyOTHER | 4 | Jan 30, 2013 | clinicaltrials |
| NCT01291082 | Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)(METAMARBO) | unknown | — | 50 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01266811 | A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Phase 3 | 0 | Centocor, Inc.INDUSTRY | 14 | Jan 28, 2013 | clinicaltrials |
| NCT01777451 | Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis(NEFIMAR) | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
| NCT00635193 | Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) | completed | Phase 1 / Phase 2 | 138 | AbbVie (prior sponsor, Abbott)INDUSTRY | 9 | Jan 18, 2013 | clinicaltrials |
| NCT01345357 | Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma | completed | Phase 1 | 24 | CephalonINDUSTRY | 2 | Jan 18, 2013 | clinicaltrials |
| NCT01209689 | A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy | terminated | Phase 3 | 113 | Hoffmann-La RocheINDUSTRY | 19 | Jan 17, 2013 | clinicaltrials |
| NCT00699374 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | terminated | Phase 3 | 1,075 | PfizerINDUSTRY | 23 | Jan 14, 2013 | clinicaltrials |
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials